Rigel Pharmaceuticals (RIGL) Posts Wider than Expected Q4 Loss of 36c/Share

March 6, 2012 7:36 AM

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q4 EPS of ($0.36), $0.08 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.

No results found